Noriko Iwamoto

3.8k total citations · 2 hit papers
104 papers, 2.7k citations indexed

About

Noriko Iwamoto is a scholar working on Molecular Biology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Noriko Iwamoto has authored 104 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 30 papers in Infectious Diseases and 20 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Noriko Iwamoto's work include COVID-19 Clinical Research Studies (21 papers), SARS-CoV-2 and COVID-19 Research (19 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). Noriko Iwamoto is often cited by papers focused on COVID-19 Clinical Research Studies (21 papers), SARS-CoV-2 and COVID-19 Research (19 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). Noriko Iwamoto collaborates with scholars based in Japan, United States and Belgium. Noriko Iwamoto's co-authors include Yoshito Kumagai, Takashi Shimada, Mikio Furuse, Masayuki Yamamoto, Li Li, Makoto Kobayashi, Yaeko Nakajima‐Takagi, Hiroshi Kaneko, Yoshiko Wada and Yuko Nakayama and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Noriko Iwamoto

96 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Antioxidant Defense System Keap1-Nrf2 Comprises a Multiple Sensing Mechanism for Responding to a Wide Range of Chemical Compounds

2008 558 citations Makoto Kobayashi, Li Li et al. Molecular and Cellular Biology profile →
Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan

2021 167 citations Mugen Ujiie, Shinya Tsuzuki et al. profile →

Peers

Noriko Iwamoto

IMMUN

NEURO

EPIDE

ONCOL

Piero Del Boccio Italy

Vikas Misra United States

Tao Wen China

Chia‐Hung Yen Taiwan

Yuan Li China

Xiaoli Li China

Stephan Immenschuh Germany

Fanfan Zhou Australia

P. Rieber Germany

Xia Wang China

Piero Del Boccio Italy

Noriko Iwamoto

1.7k ×1.1

277 ×0.6

IMMUN

111 ×0.4

NEURO

136 ×0.5

EPIDE

252 ×1.0

ONCOL

Citations per year, relative to Noriko Iwamoto Noriko Iwamoto (= 1×) peers Piero Del Boccio

Countries citing papers authored by Noriko Iwamoto

Since Specialization

Citations

This map shows the geographic impact of Noriko Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Iwamoto more than expected).

Fields of papers citing papers by Noriko Iwamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriko Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Iwamoto. The network helps show where Noriko Iwamoto may publish in the future.

Co-authorship network of co-authors of Noriko Iwamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Noriko Iwamoto. A scholar is included among the top collaborators of Noriko Iwamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noriko Iwamoto. Noriko Iwamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Itoh, Naoya, Masahiro Ishikane, Noriko Iwamoto, et al.. (2025). Duration of infectious virus shedding of SARS-CoV-2 Omicron variant among immunocompromised patients. Journal of Infection and Chemotherapy. 31(4). 102631–102631. 2 indexed citations

Miura, Fuminari, Masahiro Ishikane, Noriko Iwamoto, et al.. (2025). Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the Congo. Science Translational Medicine. 17(805). eads4773–eads4773.

Iwamoto, Noriko, et al.. (2024). Characteristics of Streptococcal Toxic Shock Syndrome Caused by Different Beta-hemolytic Streptococci Species: A Single-center Retrospective Study. Open Forum Infectious Diseases. 11(9). ofae486–ofae486. 2 indexed citations

Nomoto, Hidetoshi, Noriko Iwamoto, Kei Yamamoto, et al.. (2024). Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma. Journal of Infection and Chemotherapy. 30(8). 793–795. 5 indexed citations

Nakamoto, Takato, Noriko Iwamoto, Keiji Nakamura, et al.. (2024). COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production. BMC Infectious Diseases. 24(1). 1197–1197.

Hart, William S., Robin N. Thompson, Masahiro Ishikane, et al.. (2024). Modelling the effectiveness of an isolation strategy for managing mpox outbreaks with variable infectiousness profiles. Nature Communications. 15(1). 7112–7112. 4 indexed citations

Shoji, Kensuke, Yusuke Asai, Nobuaki Matsunaga, et al.. (2024). Comparison of clinical characteristics and severity of COVID-19 with or without viral co-infection in hospitalized children. Journal of Infection and Chemotherapy. 31(2). 102520–102520. 1 indexed citations

Minegishi, Yuriko, Noriko Iwamoto, Takashi Shimada, et al.. (2023). 149 Simultaneous identification of KRAS mutation-carrying multiple neoepitopes by differential ion mobility-assisted targeted-mass spectrometry. SHILAP Revista de lepidopterología. A169–A169. 1 indexed citations

Itoh, Naoya, Hanako Kurai, Ichiro Kawamura, et al.. (2023). A nationwide cross-sectional study using a web-based questionnaire survey of the duration of isolation of COVID-19 inpatients with cancer at Japanese cancer centers. Journal of Infection and Chemotherapy. 29(12). 1185–1188. 1 indexed citations

10.

Yamamoto, Kei, Tetsuya Suzuki, Michiyo Suzuki, et al.. (2023). Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-λ3, CCL17, and calprotectin considering the timing of clinical need for prediction. PLoS ONE. 18(3). e0279897–e0279897.

11.

Ujiie, Mugen, Takato Nakamoto, Noriko Iwamoto, & Shinya Tsuzuki. (2023). Large-scale resurgence of herpangina in Japan, following the easing of COVID-19 measures. IJID Regions. 10. 15–17. 3 indexed citations

12.

Shoji, Kensuke, Yusuke Asai, Takayuki Akiyama, et al.. (2023). Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis. Journal of Infection and Chemotherapy. 29(9). 930–933. 5 indexed citations

13.

Iwamoto, Noriko, Yoshinobu Koguchi, Akinobu Hamada, et al.. (2022). A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics. The Analyst. 147(19). 4275–4284. 4 indexed citations

14.

Tsuzuki, Shinya, Sho Saito, Shin-ichiro Hattori, et al.. (2022). Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan. Journal of Infection and Chemotherapy. 28(9). 1340–1343. 1 indexed citations

15.

Ishikane, Masahiro, Hiroyuki Unoki‐Kubota, Satoshi Kutsuna, et al.. (2022). Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 panel, a rapid multiplex PCR method for the diagnosis of COVID-19. Journal of Infection and Chemotherapy. 28(6). 729–734. 7 indexed citations

16.

Ishikane, Masahiro, Mari Terada, Akihiro Matsunaga, et al.. (2022). Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection. International Journal of Infectious Diseases. 119. 18–20.

17.

Ishikane, Masahiro, Souichi Yamada, Noriko Iwamoto, et al.. (2021). Varicella pneumonia in an immunocompetent, unvaccinated man: A case report. IJID Regions. 2. 60–62. 3 indexed citations

18.

Shoji, Kensuke, Takayuki Akiyama, Shinya Tsuzuki, et al.. (2021). Clinical Characteristics of Hospitalized COVID-19 in Children: Report From the COVID-19 Registry in Japan. Journal of the Pediatric Infectious Diseases Society. 10(12). 1097–1100. 11 indexed citations

19.

Kobayashi, Makoto, Li Li, Noriko Iwamoto, et al.. (2008). The Antioxidant Defense System Keap1-Nrf2 Comprises a Multiple Sensing Mechanism for Responding to a Wide Range of Chemical Compounds. Molecular and Cellular Biology. 29(2). 493–502. 558 indexed citations breakdown →

20.

Yoshioka, Takao, Noriko Iwamoto, Sunao Shimizu, et al.. (1995). Down regulation of glucocorticoid receptor expressions in young patients with steroid-resistant nephrotic syndrome.. Japanese journal of pediatric nephrology. 8(2). 123–127. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact